Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.
Therapeutic advances in hematology
View this publicationTherapeutic advances in hematology
View this publicationNature communications
View this publicationNature communications
View this publicationAlzheimer's & dementia : the journal of the Alzheimer's Association
View this publicationEuropean journal of immunology
View this publicationTranslational vision science & technology
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationThe New England journal of medicine
View this publicationJournal of nuclear medicine : official publication, Society of Nuclear Medicine
View this publicationEuropean child & adolescent psychiatry
View this publication